banner

News Releases

None | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
Date Title
11/26/13
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
11/14/13
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer’s Disease Psychosis
11/06/13
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results
10/31/13
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson’s Disease Psychosis Trial with Pimavanserin
10/30/13
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013
09/03/13
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
08/19/13
ACADIA Pharmaceuticals Announces Appointment of Terrence Moore as Executive Vice President and Chief Commercial Officer
08/06/13
ACADIA Pharmaceuticals Reports Second Quarter 2013 Financial Results
07/30/13
ACADIA Pharmaceuticals to Announce Second Quarter 2013 Financial Results on August 6, 2013
07/02/13
ACADIA Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference on July 9, 2013
07/01/13
ACADIA Pharmaceuticals Added to Russell 2000 Index
06/18/13
ACADIA Pharmaceuticals Announces Multiple Presentations of Data from Phase III Pimavanserin Program at the 17th International Congress of Parkinson’s Disease and Movement Disorders
06/03/13
ACADIA Pharmaceuticals Announces Advancement by Allergan of Novel Glaucoma Compound into Preclinical Development
05/29/13
ACADIA Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 5, 2013
05/20/13
ACADIA Pharmaceuticals Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Public Offering of Common Stock
05/20/13
ACADIA Pharmaceuticals Added to NASDAQ Biotechnology Index
05/15/13
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
05/14/13
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
05/07/13
ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results
04/30/13
ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013
04/25/13
ACADIA Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference on April 30, 2013
04/11/13
ACADIA Pharmaceuticals Announces Expedited Path to NDA Filing for Pimavanserin Following Meeting with FDA
03/20/13
ACADIA Announces Presentation of Data from Its Pivotal Phase III Parkinson’s Disease Psychosis Study with Pimavanserin at the American Academy of Neurology Annual Meeting
03/13/13
ACADIA Pharmaceuticals to Present at the 25th Annual ROTH Conference on March 19, 2013
03/12/13
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
03/05/13
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2012 Financial Results on March 12, 2013
02/25/13
ACADIA Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013
02/05/13
ACADIA Pharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference on February 12, 2013
01/22/13
ACADIA Pharmaceuticals Announces Election of Stephen R. Biggar to Its Board of Directors